Avidity Biosciences
RNAM
#1793
Rank
NZ$19.30 B
Marketcap
NZ$124.99
Share price
0.00%
Change (1 day)
119.89%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.30 Billion

As of March 2026 Avidity Biosciences has a market cap of NZ$19.30 Billion. This makes Avidity Biosciences the world's 1793th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.30 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$262.83 B 1,261.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$186.65 B 866.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.11 B-83.86%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.20 B-52.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.23 B-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.4 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.76 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.87 B-74.75%๐Ÿ‡บ๐Ÿ‡ธ USA